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A Case of Erythema Elevatum Diutinum
Associated with IgA Monoclonal Gammopathy and Multiple Myeloma
Shadi Jarjous M.D., Cheryl Bloomfield M.D., and James Ross M.D., F.A.C.P.; Lehigh Valley Health Network, Allentown, Pennsylvania

Introduction

Case Description

Physical Exam

Discussion

• E rythema Elevatum Diutinum (EED) is a rare type
of chronic leukocytoclastic vasculitis characterized
by symmetric violaceous, red, or yellowish papules,
plaques, or nodules.
• T hese are typically seen on the extensor surfaces of
the body, mostly involving the extremities, without any
systemic vasculopathy.
• U sually, it presents at middle age and is associated
with arthralgia, peripheral ulcerative keratitis, and
pulmonary infiltrates.
• E ED has been reportedly associated with multiple
systemic diseases:
n R
 ecurrent bacterial infections (streptococcal) and
viral infections (HBV, HHV-6, and HIV).
n M
 yelodysplastic syndrome, lymphoma, IgA
monoclonal gammopathy, multiple myeloma.
n R
 heumatoid arthritis, systemic lupus
erythematosus, Wegener’s granulomatosis, and
cryoglobulinemia.
n C
 eliac disease, ulcerative colitis, Crohn’s disease.
n Pyoderma gangrenosum.
n Hyperimmunoglobulinema D syndrome.
n Relapsing polychondritis.
n P
 OEMS syndrome (polyneuropathy, organomegaly,
endocrinopathy, monoclonal gammopathy, and
skin lesions).
• E ED is usually treated with dapsone and
corticosteroids.

History
• C .C. is now a 41 years old Hispanic female who initially
presented to the emergency department in 2006 after
she developed an itchy, burning, purple rash (papules,
plaques, and nodules) on her elbows, knees and
posterior thighs.
• A ppearance of these lesions was preceded by months
of widespread joints pain.
• P atient was referred to a dermatologist who suspected
EED and placed the patient on dapsone.
• T he diagnosis was confirmed with a biopsy of the skin
lesions.
• P atient responded dramatically to the dapsone with
rapid resolution of existing rash. However, she had
multiple relapses every time she stopped taking the
medication.

Investigational studies
• G iven the potential association of EED with multiple systemic diseases, the
patient had an extensive work up.
• A ll serologic testing were negative, including ANA, RF, CCP, tTG IgA Ab, C- and
P-ANCA, and complement levels.
•O
 ther negative work up includes TSH, G6PD, ASO, HIV, and hepatitis panel.
• I ron studies were consistent with iron deficiency anemia.
• S erum protein electrophoresis and immunofixation were initially negative.
However, a repeated SPEP couple years later showed evidence of IgA kappa
monoclonal protein (monoclonal gammopathy).
• B one marrow biopsy showed normocellular marrow involved by a clonal
plasma cell disorder.
• S keletal survey showed no suspicious lesions.

•W
 e report the development of IgA monoclonal
gammopathy and later multiple myeloma in a patient
with chronic EED on dapsone therapy.
• E ED is an uncommon disease and its association with
systemic disorders, including neoplastic diseases, is
exceedingly rare.
• T his case emphasizes the need for extensive work up
and close surveillance of patients with EED to diagnose
life-threatening systemic diseases early enough to
have a chance to successfully treat the associated
morbidities.

Patient Progress
• T he hematologist diagnosed the patient with asymptomatic smoldering
myeloma and continues to follow her closely.
• N o treatment at this time

